Join us on 18 May to discover the Opportunities for interacting with EU Agencies throughout development.

We are pleased to announce that NDAs Dr. Rosalind Cox, Principal Consultant will be providing:

  • An overview of the opportunities for interacting with National Regulatory Agencies and EMA throughout development
  • Advice on how to optimise your interactions
  • Specific considerations for companies qualifying as Small or Medium Enterprises in the EU
  • Procedure or product type specific interactions

Finally, the webinar will provide input to help you build your Health Authority Interaction Plan with key Regulatory Agencies.

Dr. Rosalind Cox will also be available to answer any questions you may have, offering you the benefit of her knowledge and experience.

Dr. Cox has held senior positions in European and International Regulatory Affairs within the pharmaceutical industry for 24 years, followed by six years at NDA. She is experienced in Centralised and Mutual Recognition procedures, initial applications, line extensions and Scientific Advice (national and EMA). Roz specialises in European Regulatory strategy within the context of global development, particularly for development products.


Click here to book your place today.


Dr. Rosalind Cox

Principal Consultant


Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.